Lipidomic Signatures in Pediatric Metabolic Disorders
Metabolites · 28.12.2025 · 16 (1) · 33
DOI: 10.3390/metabo16010033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 28.12.2025. Verfasst von Monica Narvaez-Rivas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology & Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lipids are essential biomolecules involved in membrane structure, energy storage, and intracellular signaling. Dysregulation of lipid metabolism (dyslipidemia) plays a central role in a wide spectrum of pediatric metabolic disorders, including both inherited and acquired conditions. Recent and rapid advances in mass spectrometry-based lipidomics have enabled high-resolution profiling of more than one-thousand lipid species, facilitating the discovery of disease-specific lipid signatures that were previously undetectable with conventional biochemical assays. In parallel, the rising prevalence of pediatric obesity, diabetes, asthma, metabolic dysfunction-associated steatotic liver disease (MASLD; formerly referred to as non-alcoholic fatty liver disease or NAFLD) and cancers has accelerated research aimed at uncovering molecular pathways underlying these conditions. Lipidomic approaches have also improved the identification and characterization of rare metabolic disorders. As analytical technologies continue to advance, lipidomics is poised to become a cornerstone of precision medicine in pediatrics, offering new opportunities for early diagnosis, risk stratification, and therapeutic targeting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pathology & Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
ORCID-Profile: Monica Narvaez-Rivas
Zitieren
APA
Narvaez-Rivas, M., & Setchell, K. D. R. (2025). Lipidomic Signatures in Pediatric Metabolic Disorders. Metabolites, 16(1), 33. https://doi.org/10.3390/metabo16010033
Vancouver
Narvaez-Rivas M, Setchell KDR. Lipidomic Signatures in Pediatric Metabolic Disorders. Metabolites. 2025;16(1):33. doi:10.3390/metabo16010033
BibTeX
@article{NarvaezRivas2025,
author = {Narvaez-Rivas, Monica and Setchell, Kenneth D R},
title = {Lipidomic Signatures in Pediatric Metabolic Disorders},
journal = {Metabolites},
year = {2025},
volume = {16},
number = {1},
pages = {33},
doi = {10.3390/metabo16010033}
}
EUVIMED